Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Nasal Acai polysaccharides potentiate innate immunity to protect against pulmonary Francisella tularensis and Burkholderia pseudomallei Infections.

Skyberg JA, Rollins MF, Holderness JS, Marlenee NL, Schepetkin IA, Goodyear A, Dow SW, Jutila MA, Pascual DW.

PLoS Pathog. 2012;8(3):e1002587. doi: 10.1371/journal.ppat.1002587. Epub 2012 Mar 15.

2.

Mucosal immunopathogenesis of Francisella tularensis.

Metzger DW, Bakshi CS, Kirimanjeswara G.

Ann N Y Acad Sci. 2007 Jun;1105:266-83. Epub 2007 Mar 29. Review.

PMID:
17395728
3.

Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis.

Kirimanjeswara GS, Olmos S, Bakshi CS, Metzger DW.

Immunol Rev. 2008 Oct;225:244-55. doi: 10.1111/j.1600-065X.2008.00689.x. Review.

4.

Immunotherapy for tularemia.

Skyberg JA.

Virulence. 2013 Nov 15;4(8):859-70. doi: 10.4161/viru.25454. Epub 2013 Jun 19. Review.

5.

Multifaceted effects of Francisella tularensis on human neutrophil function and lifespan.

Kinkead LC, Allen LA.

Immunol Rev. 2016 Sep;273(1):266-81. doi: 10.1111/imr.12445. Review.

6.

Consensus on the development of vaccines against naturally acquired melioidosis.

Limmathurotsakul D, Funnell SG, Torres AG, Morici LA, Brett PJ, Dunachie S, Atkins T, Altmann DM, Bancroft G, Peacock SJ; Steering Group on Melioidosis Vaccine Development.

Emerg Infect Dis. 2015 Jun;21(6). doi: 10.3201/eid2106.141480.

7.

New therapeutic approaches for treatment of tularaemia: a review.

Boisset S, Caspar Y, Sutera V, Maurin M.

Front Cell Infect Microbiol. 2014 Mar 28;4:40. doi: 10.3389/fcimb.2014.00040. eCollection 2014. Review.

8.

Adjuvant materials that enhance bovine γδ T cell responses.

Hedges JF, Holderness J, Jutila MA.

Vet Immunol Immunopathol. 2016 Nov 15;181:30-38. doi: 10.1016/j.vetimm.2016.03.010. Epub 2016 Mar 17. Review.

PMID:
27021513
9.

Autophagy and burkholderia.

Devenish RJ, Lai SC.

Immunol Cell Biol. 2015 Jan;93(1):18-24. doi: 10.1038/icb.2014.87. Epub 2014 Oct 21. Review.

PMID:
25331551
10.

Inhaled innate immune ligands to prevent pneumonia.

Evans SE, Tuvim MJ, Fox CJ, Sachdev N, Gibiansky L, Dickey BF.

Br J Pharmacol. 2011 May;163(1):195-206. doi: 10.1111/j.1476-5381.2011.01237.x. Review.

11.

Does Type I Interferon Limit Protective Neutrophil Responses during Pulmonary Francisella Tularensis Infection?

Furuya Y, Steiner D, Metzger DW.

Front Immunol. 2014 Jul 23;5:355. doi: 10.3389/fimmu.2014.00355. eCollection 2014. Review. No abstract available.

12.

IFN-λ: A New Inducer of Local Immunity against Cancer and Infections.

Lasfar A, Zloza A, de la Torre A, Cohen-Solal KA.

Front Immunol. 2016 Dec 15;7:598. doi: 10.3389/fimmu.2016.00598. eCollection 2016. Review.

Supplemental Content

Support Center